The aim of this study was to detect treatment‐induced changes in the tumor and to identify differentially expressed proteins (DEPs) and altered signaling pathways between TN and NAT tumors, and their potential correlation with different clinical parameters. This evidence concerns the gene BRD2 and neoplasm.